Article
Clinical cancer genomics: how soon is now?
The Journal of pathology - 1 Jan 2011
Taylor Barry S, Ladanyi Marc
Abstract excerpt
Germline and somatic alterations in DNA mediate the genesis and progression of human cancers. Not only do these events represent the molecular underpinnings of disease but many are of immense clinical importance as diagnostic markers and therapeutic targets. In fact, rapidly evolving sequencing technologies have empowered enormous growth in the breadth and depth of cancer genome characterization. Whether these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
